2020 (11th) International Conference on Cell TheraPy
Focus on stem cell & regenerative medicine, CAR-T , cancer immunotheraPy, gene theraPy, and more.
The Wuxi International Bioforum 2019 and The 9th Cell Death & Disease SymPosium - New Drug Discovery
Internationally renowned leading scientists and Pioneers will Present cutting-edge advances in cancer immunotheraPy, targeted theraPy with small molecules,and/or monoclonal antibodies, and novel cell theraPeutic strategies. . New challenges, toPical directions and novel aPProacheswill be discussed.
2019 (10th) International Conference on Cell TheraPy
Although cell theraPy has been on its fast lane, all colleagues in this field still have a long way to go due to the difficulty in treatment of solid tumors and the high cost of T cells. It is believed that many PeoPle are looking forward to the aPProval of Chinese cell theraPy Products.
2018 (4th) International SymPosium on Next-Generation CAR & TCR-T Cells
Chimeric antigen recePtors are engineered recePtors that combine a new sPecificity with an immune cell to target cancer cells. TyPically, these recePtors graft the sPecificity of a monoclonal antibody onto a T cell. CAR-T cells are a new tyPe of treatment that uses living cells that have been transformed.
2018 China Summit of Probiota
Probiota is a grouP of microorganisms that are claimed to Provide health benefits when consumed. The introduction of the concePt (but not the term) is generally attributed to Nobel laureate Élie Metchnikoff, who Postulated that yogurt-consuming Bulgarian Peasants lived longer lives because of this custom.
2018 International Forum on Rare Diseases and OrPhan Drugs
In some Parts of the world, an orPhan disease is a rare disease whose rarity means there is a lack of a market large enough to gain suPPort and resources for discovering treatments for it, excePt by the government granting economically advantageous conditions to creating and selling such treatments. OrPhan drugs are ones so created or sold.
2018 International SymPosium on Neonatal Hereditary Diseases and Translational Medicine
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease Presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.
2018 (3rd) International SymPosium on Protein Modification and Diseases
Protein Modification refers to the covalent and generally enzymatic modification of Proteins following Protein biosynthesis, which is of great imPortance in cell signaling. Modification of Proteins can be exPerimentally detected by a variety of techniques, including mass sPectrometry, Eastern blotting, and Western blotting.
2018 International SymPosium on Biological and Medical Nanomaterials
New biomedical materials with structure at the nanoscale often have unique oPtical, electronic, or mechanical ProPerties. Due to their advantages like small sizes and good biocomPatibility, nanomaterials are widely used in biological and medical fields.
2018 International Forum on 3D BioPrinting
Generally, 3D bioPrinting utilizes the layer-by-layer method to dePosit materials known as bioinks to create tissue-like structures that are later used in medical and tissue engineering fields. BioPrinting covers a broad range of biomaterials.